RedHill Biopharma (RDHL) Raw Materials (2022 - 2024)

RedHill Biopharma (RDHL) has disclosed Raw Materials for 3 consecutive years, with $513000.0 as the latest value for Q4 2024.

  • Quarterly Raw Materials fell 38.04% to $513000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $513000.0 through Dec 2024, down 38.04% year-over-year, with the annual reading at $513000.0 for FY2024, 38.04% down from the prior year.
  • Raw Materials for Q4 2024 was $513000.0 at RedHill Biopharma, down from $828000.0 in the prior quarter.
  • The five-year high for Raw Materials was $1.8 million in Q4 2022, with the low at $513000.0 in Q4 2024.
  • Average Raw Materials over 3 years is $1.0 million, with a median of $828000.0 recorded in 2023.
  • The sharpest move saw Raw Materials plummeted 53.92% in 2023, then crashed 38.04% in 2024.
  • Over 3 years, Raw Materials stood at $1.8 million in 2022, then tumbled by 53.92% to $828000.0 in 2023, then plummeted by 38.04% to $513000.0 in 2024.
  • According to Business Quant data, Raw Materials over the past three periods came in at $513000.0, $828000.0, and $1.8 million for Q4 2024, Q4 2023, and Q4 2022 respectively.